Novome Biotechnologies
生物技术研究
South San Francisco,CA 3,705 位关注者
Engineering Living Medicines for Chronic Diseases
关于我们
Novome is building genetically engineered microbial medicines (GEMMs) that perform defined activities in the human gut to treat chronic diseases. We have developed the first platform for controlled colonization of the gut with engineered therapeutic bacteria, and are applying this to multiple disease areas as well as expanding our platform capabilities. Our lead program in enteric hyperoxaluria is currently in Phase 2 clinical trials, and we are focusing current research efforts on making a microbial cell therapy to treat inflammatory bowel disease (IBD).
- 网站
-
https://novomebio.com
Novome Biotechnologies的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- South San Francisco,CA
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Microbiome、Synthetic Biology和Therapeutics
地点
-
主要
279 E Grand Ave
US,CA,South San Francisco,94080